Home
Numerate, Inc.

Numerate, Inc. Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainnumerate.com

Year Founded2007

Employees51 - 200

Annual Revenue$15M - $25M

Numerate, Inc.

Numerate, Inc. (including company regionals)

numerate.com

See more website traffic and engagement information

Numerate, Inc. Revenue up to November 2025 is 15M - 25M

revenue generated by Numerate, Inc. top domains

Numerate, Inc. top domains revenue over 3 years

Revenue for Numerate, Inc. top domains

numerate.com15M - 25M

See more with Sales Intelligence

Total visits to Numerate, Inc.'s top domains

Understand Numerate, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Numerate, Inc.'s top domains

Analyze Numerate, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Numerate, Inc.'s top domains

See how Numerate, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Numerate, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

ngmbio.comCompany NameNGM BioEmployees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$75M - $100MTotal visits5.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Numerate, Inc.

These are the website technologies, by industry, used by Numerate, Inc. top domains

Widget (5)

Twemoji

Advertising (3)

Google Adsense

Content Management System (3)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Numerate, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNumerate, Inc. receives financing of $2M in Small Business Innovation Research.Numerate, Inc., a San Bruno, CA-based computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, received a $2m Small Business Innovation Research (SBIR) Phase II grant.

NewsNumerate, Inc. partners with CUBRC.Under the contract Numerate will be extending the capabilities of and, in collaboration with CUBRC, validating and deploying its ToxTool system, developed and validated with CUBRC under two previous contracts with DTRA (under Prime Contracts FA8075-14-C-0092 and SP00700-00D-3180).

NewsTakeda Pharmaceuticals partnered with Numerate, Inc. on Jun 1st '17.The search for partners with unique drug discovery capabilities prompted Takeda to enter into an alliance with Numerate.